Branched-Chain Amino Acids in Liver Diseases: Complexity and Controversy
Nutrients · 14.06.2024 · 16 (12) · 1875
DOI: 10.3390/nu16121875 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 14.06.2024. Verfasst von Yaqi Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical …. Hauptthemen laut MEDLINE: Amino Acids, Branched-Chain, Liver Diseases. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Fundamental Research Funds for the Central Universities, the opening foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University Schoo…, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Branched-chain amino acids (BCAAs), as essential amino acids, engage in various physiological processes, such as protein synthesis, energy supply, and cellular signaling. The liver is a crucial site for BCAA metabolism, linking the changes in BCAA homeostasis with the pathogenesis of a variety of liver diseases and their complications. Peripheral circulating BCAA levels show complex trends in different liver diseases. This review delineates the alterations of BCAAs in conditions including non-alcoholic fatty liver disease, hepatocellular carcinoma, cirrhosis, hepatic encephalopathy, hepatitis C virus infection, and acute liver failure, as well as the potential mechanisms underlying these changes. A significant amount of clinical research has utilized BCAA supplements in the treatment of patients with cirrhosis and liver cancer. However, the efficacy of BCAA supplementation in clinical practice remains uncertain and controversial due to the heterogeneity of studies. This review delves into the complicated relationship between BCAAs and liver diseases and tries to untangle what role BCAAs play in the occurrence, development, and outcomes of liver diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, National Medical Center for Infectious Diseases, Collaborative Innovation Center for Di…
- Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou 310024, China.
Förderung
- the Fundamental Research Funds for the Central Universities
- the opening foundation of the State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, Zhejiang University Schoo…
- Fundamental Research Funds for the Central Universities
- First Affiliated Hospital, Zhejiang University School of Medicine
Zitieren
APA
Zhang, Y., Zhan, L., Zhang, L., Shi, Q., & Li, L. (2024). Branched-Chain Amino Acids in Liver Diseases: Complexity and Controversy. Nutrients, 16(12), 1875. https://doi.org/10.3390/nu16121875
Vancouver
Zhang Y, Zhan L, Zhang L, Shi Q, Li L. Branched-Chain Amino Acids in Liver Diseases: Complexity and Controversy. Nutrients. 2024;16(12):1875. doi:10.3390/nu16121875
BibTeX
@article{Zhang2024,
author = {Zhang, Yaqi and Zhan, Luqi and Zhang, Lingjian and Shi, Qingmiao and Li, Lanjuan},
title = {Branched-Chain Amino Acids in Liver Diseases: Complexity and Controversy},
journal = {Nutrients},
year = {2024},
volume = {16},
number = {12},
pages = {1875},
doi = {10.3390/nu16121875}
}
EUVIMED